Morgan Stanley upgraded shares of BlackLine (NASDAQ:BL – Free Report) from an equal weight rating to an overweight rating in a research report report published on Monday morning, MarketBeat.com reports. The firm currently has $70.00 price objective on the technology company’s stock, up from their previous price objective of $60.00. A number of other equities […]

Johnson Controls International (NYSE:JCI – Get Free Report) had its target price increased by stock analysts at Oppenheimer from $79.00 to $86.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Oppenheimer’s price target suggests a potential upside of 13.92% from […]

Barclays reissued their underweight rating on shares of Apple (NASDAQ:AAPL – Free Report) in a report published on Tuesday morning, Benzinga reports. They currently have a $186.00 target price on the iPhone maker’s stock. AAPL has been the subject of a number of other reports. UBS Group boosted their price objective on Apple from $190.00 […]

Reinsurance Group of America (NYSE:RGA – Get Free Report) had its price target lifted by equities researchers at Piper Sandler from $237.00 to $242.00 in a report issued on Wednesday, Benzinga reports. The firm presently has an “overweight” rating on the insurance provider’s stock. Piper Sandler’s price target would suggest a potential upside of 12.74% […]

Piper Sandler reissued their overweight rating on shares of Alphabet (NASDAQ:GOOGL – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. Piper Sandler currently has a $200.00 target price on the information services provider’s stock. Several other research analysts also recently commented on the company. JMP Securities reissued a market […]

Investment analysts at Stephens initiated coverage on shares of Danaher (NYSE:DHR – Get Free Report) in a report released on Tuesday, MarketBeat.com reports. The brokerage set an “overweight” rating and a $315.00 price target on the conglomerate’s stock. Stephens’ price objective would suggest a potential upside of 14.98% from the stock’s current price. A number […]

NovoCure (NASDAQ:NVCR – Get Free Report) had its price target lowered by stock analysts at Evercore ISI from $21.00 to $18.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has an “in-line” rating on the medical equipment provider’s stock. Evercore ISI’s price target suggests a potential upside of 16.13% […]

Hologic (NASDAQ:HOLX – Get Free Report) was downgraded by research analysts at Citigroup from a “buy” rating to a “neutral” rating in a research report issued on Tuesday, Marketbeat Ratings reports. They currently have a $85.00 target price on the medical equipment provider’s stock, down from their prior target price of $95.00. Citigroup’s price target […]

IGM Biosciences (NASDAQ:IGMS – Get Free Report) was downgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “underweight” rating in a research note issued to investors on Tuesday, Marketbeat.com reports. They currently have a $9.00 target price on the stock, down from their previous target price of $12.00. JPMorgan Chase […]

Centene (NYSE:CNC – Get Free Report)‘s stock had its “overweight” rating reaffirmed by research analysts at Cantor Fitzgerald in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $90.00 price objective on the stock. Cantor Fitzgerald’s target price suggests a potential upside of 23.92% from the stock’s previous close. Other […]

Bio-Rad Laboratories (NYSE:BIO – Get Free Report) was upgraded by stock analysts at Citigroup from a “neutral” rating to a “buy” rating in a report released on Tuesday, MarketBeat reports. The firm presently has a $400.00 price objective on the medical research company’s stock, up from their prior price objective of $350.00. Citigroup’s price target […]

Insulet (NASDAQ:PODD – Get Free Report) had its price target upped by equities research analysts at Citigroup from $250.00 to $275.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the medical instruments supplier’s stock. Citigroup’s price objective indicates a potential upside of 18.21% from […]

HP (NYSE:HPQ – Get Free Report) was downgraded by equities research analysts at Citigroup from a “buy” rating to a “neutral” rating in a research note issued to investors on Tuesday, Marketbeat.com reports. They currently have a $37.00 price objective on the computer maker’s stock. Citigroup’s price target would indicate a potential upside of 5.20% […]

Steel Dynamics (NASDAQ:STLD – Get Free Report) was upgraded by research analysts at Bank of America from a “neutral” rating to a “buy” rating in a report issued on Tuesday, Marketbeat reports. The brokerage currently has a $155.00 price target on the basic materials company’s stock, up from their prior price target of $140.00. Bank […]

TD Cowen upgraded shares of Accenture (NYSE:ACN – Free Report) from a hold rating to a buy rating in a report published on Monday, Marketbeat Ratings reports. TD Cowen currently has $400.00 price target on the information technology services provider’s stock, up from their prior price target of $321.00. A number of other equities research […]

Cantor Fitzgerald reaffirmed their neutral rating on shares of Alphabet (NASDAQ:GOOGL – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. Cantor Fitzgerald currently has a $190.00 price target on the information services provider’s stock. Other equities research analysts have also recently issued reports about the stock. Rosenblatt Securities reaffirmed […]

Amazon.com (NASDAQ:AMZN) had its price target lifted by Truist Financial from $230.00 to $265.00 in a research note published on Monday, Benzinga reports. The firm currently has a buy rating on the e-commerce giant’s stock. AMZN has been the topic of a number of other reports. Evercore ISI upped their price target on shares of […]

Alcoa (NYSE:AA – Get Free Report) was upgraded by Bank of America from a “neutral” rating to a “buy” rating in a research note issued to investors on Tuesday, MarketBeat reports. The firm presently has a $52.00 price objective on the industrial products company’s stock, up from their prior price objective of $43.00. Bank of […]

Accenture (NYSE:ACN – Free Report) had its price objective boosted by Barclays from $350.00 to $415.00 in a report published on Monday, Benzinga reports. The brokerage currently has an overweight rating on the information technology services provider’s stock. Several other brokerages have also issued reports on ACN. Royal Bank of Canada increased their target price […]

Shopify (NYSE:SHOP – Free Report) (TSE:SHOP) had its target price increased by Citigroup from $90.00 to $103.00 in a report released on Monday morning, MarketBeat Ratings reports. Citigroup currently has a buy rating on the software maker’s stock. A number of other equities research analysts have also weighed in on SHOP. Morgan Stanley raised their […]

Equities researchers at Wolfe Research assumed coverage on shares of Incyte (NASDAQ:INCY – Get Free Report) in a research report issued to clients and investors on Tuesday, MarketBeat Ratings reports. The firm set an “outperform” rating and a $84.00 price target on the biopharmaceutical company’s stock. Wolfe Research’s target price indicates a potential upside of […]

Morgan Stanley downgraded shares of JPMorgan Chase & Co. (NYSE:JPM) from an overweight rating to an equal weight rating in a research report report published on Monday, MarketBeat.com reports. Morgan Stanley currently has $224.00 price objective on the financial services provider’s stock, up from their previous price objective of $220.00. Other equities analysts have also […]

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target increased by equities researchers at Morgan Stanley from $462.00 to $474.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm presently has an “equal weight” rating on the pharmaceutical company’s stock. Morgan Stanley’s target price indicates a potential upside of […]

Costco Wholesale (NASDAQ:COST – Free Report) had its price target increased by TD Cowen from $925.00 to $975.00 in a research note published on Monday, Benzinga reports. The brokerage currently has a buy rating on the retailer’s stock. COST has been the topic of several other reports. Truist Financial lowered shares of Costco Wholesale from […]